
Manigandan Easwaran
Experience in Phase I-IV and various exploratory studies in clinical trial domain. Sample size estimation, Development of statistical... | Bengaluru, Karnataka, India
*50 free lookup(s) per month.
No credit card required.
Manigandan Easwaran’s Emails ma****@as****.com
Manigandan Easwaran’s Phone Numbers No phone number available.
Social Media
Manigandan Easwaran’s Location Bengaluru, Karnataka, India
Manigandan Easwaran’s Expertise Experience in Phase I-IV and various exploratory studies in clinical trial domain. Sample size estimation, Development of statistical section of study protocol, inputs to desgining of CRF’s. Preparation and review of statistical analysis plans; data review, statistical evaluation of studies; documentation reporting and presentation of results. Statistical report preparation in the following therapeutic areas: Phase II – Psoriasis (safety and efficacy), Rheumatoid Arthritis (safety and efficacy), Nephrology – PK/PD, Vaccine studies (Safety, tolerability and immunogenicity of Rotavirus Vaccines) in Infants, Stem cell studies. Phase III- Diabetology – Non inferiority and superiority trials, Osteoarthritis, Osteoporosis , Oncology trials – Head & Neck cancer, Glioblastoma multiforme and Non small cell lung cancer, Stem cell studies. Statistical analysis of various exploratory studies in the field of oncology. Perform blinded statistical review to check for data discrepencies Develop programs for quality control of analysis programs Provide training on the statistical portion of the protocol to the statistical team. developing analytic dashboards. Specialties: Training and mentoring team members, project timeline management and optimal resource utilization.
Manigandan Easwaran’s Current Industry Astrazeneca
Manigandan
Easwaran’s Prior Industry
Jairam Arts And Science College Salem
|
Clinigene International
|
Ecron Acunova
|
Convergehealth By Deloitte
|
Novo Nordisk
|
Eli Lilly
|
Astrazeneca
Not the Manigandan Easwaran you were looking for?
Find accurate emails & phone numbers for over 700M professionals.
Work Experience

Astrazeneca
Statistical programming Associate Director
Wed Mar 01 2023 00:00:00 GMT+0000 (Coordinated Universal Time) — Present
Eli Lilly
Senior Research Scientist
Wed Jul 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time) — Wed Mar 01 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Eli Lilly
Senior Manager
Wed Jul 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time) — Wed Mar 01 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Novo Nordisk
Statistician Specialist
Fri Nov 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time) — Wed Jul 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Novo Nordisk
Lead Statistician
Sun Oct 01 2017 00:00:00 GMT+0000 (Coordinated Universal Time) — Fri Nov 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Novo Nordisk
Associate Lead Statistician
Sat Nov 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time) — Fri Sep 01 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Convergehealth By Deloitte
Lead Statistician (USI)
Tue Oct 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time) — Sat Nov 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Ecron Acunova
Manager, Biostatistics and Programming
Sat Oct 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) — Sun Sep 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Clinigene International
Assistant Manager - Biostatistics
Fri Apr 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) — Sat Oct 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Clinigene International
Sr. Biostatistician
Sat Jan 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) — Tue Mar 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Clinigene International
Biostatistician
Sat Nov 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time) — Wed Dec 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Jairam Arts And Science College Salem
Lecturer
Sat Jan 01 2005 00:00:00 GMT+0000 (Coordinated Universal Time) — Tue Jan 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time)